SAN FRANCISCO, Jan. 7, 2011 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on iTech Medical, Inc., (OTC Bulletin Board: IMSU), with a twelve month target price of $1.85. Ross Silver, Principal Analyst at Vista Partners stated, "iTech Medical is at an inflection point as they have received CE Marking approval to have the Muscle Pattern Recognition (MPR) System approved for sale in the European Union and received Health Canada approval to begin selling MPR in Canada, which will lead to revenue generation in 2011. We believe the MPR System to be a superior and innovative technology, relative to other testing products and strongly believe the MPR System has the ability to become the 'gold standard' of quantitative neck and back muscle assessment tools."

To download a FREE copy of the iTech Medical, Inc. research report, please visit http://www.vistapglobal.com and complete the research form to gain access to the report.

About Vista Partners:

Vista Partners LLC was founded in 2005 and has offices in California and one in Oregon. We are a Registered Investment Advisor in the States of California and Oregon. Our professional staff has backgrounds in finance, corporate communications and investment banking. Vista Partners has built a name for itself in the small cap space due to its selection of profitable investment ideas.

Disclaimer & Disclosure:

For a full list of disclaimers and disclosures, please visit our website www.vistapglobal.com or click here. 


    Contact:
    877.215.4813 or info@vistapglobal.com

SOURCE Vista Partners